$REEAF Income Statement | Understand Stock

$REEAF

$0.01 -$0.01 (60.0%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Cost of revenues
Gross loss
Operating expenses:
Research and development expenses, net
Selling, general and administrative expenses
Other expenses
Total operating expenses
Operating loss
Income (Loss) from warrants remeasurement
Financial income (expenses), net
Net loss before income tax
Taxes on income (tax benefit)
Net loss
Net comprehensive loss
Basic net loss per share (in USD per share)
Diluted net loss per share (in USD per share)
Weighted average number of ordinary shares used in computing basic net loss per share (in shares)
Class A Ordinary Shares
Total weighted average number of ordinary shares used in computing basic net loss per share (in shares)
Weighted average number of ordinary shares used in computing diluted net loss per share (in shares)
Class A Ordinary Shares
Total weighted average number of ordinary shares used in computing diluted net loss per share (in shares)

Comments